Innovative Balloon-Assisted Technique Proven Safe and Effective for Transcatheter Mitral Valve Replacement

Recent findings from an extensive international registry demonstrate that balloon-assisted anterior mitral leaflet modification (BATMAN) is a safe and efficient technique for patients undergoing transcatheter mitral valve replacement (TMVR). Presented as late-breaking research at the Society for Cardiovascular Angiography & Interventions 2025 Scientific Sessions, the study highlights the benefits of this novel approach, including shorter procedure durations.
In the United States alone, approximately four million individuals suffer from mitral valve regurgitation, the most common type of heart valve disease. TMVR offers a minimally invasive alternative to traditional open-heart surgery for repairing faulty mitral valves. However, a complication known as left ventricular outflow tract (LVOT) obstruction, which can severely impair blood flow and lead to heart failure, remains a significant concern during TMVR procedures.
The BATMAN technique was developed to mitigate this risk. The study involved 41 high-risk patients across 12 major heart centers in the U.S., Canada, and Europe. These patients underwent transseptal TMVR combined with balloon-assisted modification of the anterior mitral leaflet, aiming to prevent LVOT obstruction. The primary goals were to assess the success rate of the procedure without LVOT obstruction and to evaluate in-hospital safety, including death, stroke, or major structural complications.
Results showed that the primary efficacy endpoint was achieved in 92.7% of cases. All procedures involved successful leaflet traversal and balloon laceration, with no residual LVOT obstruction observed. The median time between leaflet modification and valve implantation was only 28 minutes, indicating a streamlined process.
Regarding safety, major adverse events occurred in 9.8% of patients, including two deaths in the Valve-in-Mitral annular calcification group and one in the Valve-in-Valve group. No structural cardiac complications or strokes were reported. According to Dr. Gennaro Giustino, lead author of the study, the BATMAN technique offers an excellent alternative to the more complex and steep-learning curve LAMPOON technique, especially beneficial in ViR and ViV procedures. This advancement provides physicians with an additional, reliable option to prevent LVOT obstruction during TMVR.
Further research is planned to refine the BATMAN method and compare its efficacy directly with existing techniques like LAMPOON, aiming to optimize patient outcomes.
Source: https://medicalxpress.com/news/2025-05-balloon-procedure-safe-effective-patients.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
How Short Bowel Syndrome Treatments Induce Cellular Changes in the Intestine: Insights from a Longitudinal Study
A groundbreaking longitudinal study reveals how GLP-2 analog therapy induces cellular remodeling in the intestine, improving nutrient absorption and reducing inflammation in short bowel syndrome patients.
New Brain Cells Identified as 'Meal Memory' Neurons May Unlock Understanding of Overeating
A groundbreaking study identifies 'meal engrams'—specialized neurons in the hippocampus that encode meal memories—offering new insights into overeating and potential obesity treatments.
Understanding Three-Person Embryos: A Scientific Breakthrough and Its Limitations for LGBTQ+ Families
Recent advancements in mitochondrial replacement therapy have enabled the birth of babies conceived with three DNA sources, but this development mainly offers medical solutions for mitochondrial diseases and doesn't significantly impact LGBTQ+ family-building options.
Novo Nordisk Collaborates with US Biotech Firm to Develop Innovative Obesity Medications
Novo Nordisk and Septerna have embarked on a groundbreaking partnership to develop oral medications targeting GPCRs for obesity and metabolic diseases, promising more convenient treatment options.



